<DOC>
	<DOCNO>NCT02153281</DOCNO>
	<brief_summary>The purpose study determine monoamine oxidase B ( MAO-B ) total distribution volume ( VT ) , phenelzine treatment extent .</brief_summary>
	<brief_title>Detecting Central Peripheral Biomarkers MDD</brief_title>
	<detailed_description>Subjects receive PET MRI scan treatment phenelzine .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Phenelzine</mesh_term>
	<criteria>1880 year age good physical health Diagnostic Statistical Manual Mental Disorders ( DSMIV ) diagnosis current major depressive episode ( MDE ) DSMIV diagnosis major depressive disorder ( MDD ) verify SCID DSMIV psychiatric consultation great 17 17 item HDRS ( Hamilton Depression Rating Scale ) . history nonresponse several different antidepressant class herbal , drug medication use ( affect CNS function ) suicide attempts drug medication use within eight week ( +5 half live medication ) history substance abuse neurotoxin use history psychotic symptom history central nervous system ( CNS ) medical illness current substance abuse test positive pregnancy test ( woman )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Depression</keyword>
	<keyword>Positron Emission Tomography ( PET )</keyword>
	<keyword>MAO-B</keyword>
</DOC>